Literature DB >> 3479756

Clonazepam-induced Tourette syndrome in a subject with hyperexplexia.

M A Gillman, R Sandyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3479756      PMCID： PMC2428168          DOI： 10.1136/pgmj.63.738.311-a

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Decreased serotoninergic activity in Tourette syndrome.

Authors:  C J Crosley
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

2.  Serum haloperidol levels in Gilles de la Tourette syndrome.

Authors:  H S Singer; P Rabins; L E Tune; J T Coyle
Journal:  Biol Psychiatry       Date:  1981-01       Impact factor: 13.382

3.  Hyperekplexia exacerbated by occlusion of posterior thalamic arteries.

Authors:  R G Fariello; R J Schwartzman; S S Beall
Journal:  Arch Neurol       Date:  1983-04

4.  Startle disease or hyperekplexia: further delineation of the syndrome.

Authors:  F Andermann; D L Keene; E Andermann; L F Quesney
Journal:  Brain       Date:  1980-12       Impact factor: 13.501
  4 in total
  4 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 2.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

Review 4.  Tics induced by antiepileptic drugs: a pragmatic review.

Authors:  James Peters; Nirosen Vijiaratnam; Heather Angus-Leppan
Journal:  J Neurol       Date:  2020-08-17       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.